Edelweiss Mid Cap Fund Regular-Growth
The fund is rated 4.5 stars. The strongest areas were investment selection within each asset type, investment selection within each industry, and balance between returns and downside risk. Higher annual fee of 1.89% and above-average fund size of Rs 18,693.49 crore were minor drawbacks.
This fund has a good track record with Asset Selection/Timing, a good track record with Stock Selection/Timing, a good risk-reward ratio. It is important to note, however, that this fund has a 18693.492 AUM and a 1.89 expense ratio. Considering all these factors, we have rated this fund as 4.5 star.
எங்கள் score நீண்டகால performance, risk மற்றும் consistency-ஐ மதிப்பிடுகிறது — past returns மட்டும் அல்ல.
Returns
21 Sep 2026 நிலவரப்படி
Risk ratios
31 Aug 2026 நிலவரப்படி
Portfolio
31 Aug 2026 நிலவரப்படி
Market-cap பிரிவு
துறை ஒதுக்கீடு
Holdings (99)
| Holding | Fund-இன் % | மதிப்பு | பங்குகள் |
|---|---|---|---|
| The Federal Bank Ltd. | 3.73% | ₹742.79 Cr | 2,08,23,817 |
| Multi Commodity Exchange Of India Ltd. | 2.69% | ₹534.37 Cr | 15,71,687 |
| Coforge Ltd. | 2.18% | ₹432.76 Cr | 21,79,829 |
| Solar Industries India Ltd. | 2.06% | ₹410.06 Cr | 2,03,930 |
| Persistent Systems Ltd. | 2.04% | ₹405.56 Cr | 7,24,918 |
| City Union Bank Ltd. | 1.98% | ₹393.12 Cr | 1,71,52,756 |
| BSE Ltd. | 1.97% | ₹392.63 Cr | 11,96,328 |
| Marico Ltd. | 1.94% | ₹385.54 Cr | 47,01,724 |
| Fortis Healthcare Ltd. | 1.91% | ₹379.21 Cr | 41,81,418 |
| Ipca Laboratories Ltd. | 1.82% | ₹362.09 Cr | 18,33,465 |
Fund விவரங்கள்
Long term capital growth. Investments predominantly in equity and equity related securities focused on smaller companies (generally, the universe will be the companies constituting the bottom fourth by way of market capitalization of stocks listed on th
The scheme aims to generate long term capital appreciation from a portfolio that is substantially constituted of equity and equity related securities of Mid Cap companies.
Exit load of 1%, if redeemed within 90 days.